Q1 2026 · 13F-HR
Twin Securities, Inc.holdings as filed
Filed 2026-05-15 · accession 0001172661-26-002293
$206.1M
Reported value
17
Positions
2026-03-31
Period end
The Brief · Twin Securities, Inc. · Q1 2026
AI · grounded in 13F
Twin Securities, Inc. closed its position in CYBR, reducing exposure by $59.39M. The fund also exited positions in EXK and RNAGBP, totaling reductions of $49.11M and $26.34M respectively. On the buy side, the fund established new positions in RVMD for $7.55M, ACLXGBX for $6.20M, and 430 for $6.11M. Additionally, the fund increased its share count in CWAN by 2260.57%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 285512109 | EA | ELECTRONIC ARTS INC | $91.1M | 44.2% | 446,948 | Common | SOLE |
| 934423104 | WBD | WARNER BROS DISCOVERY INC | $35.7M | 17.3% | 1,299,915 | Common | SOLE |
| 185123106 | CWAN | CLEARWATER ANALYTICS HLDGS I | $27.5M | 13.4% | 1,164,090 | Common | SOLE |
| 436440101 | HO1 | HOLOGIC INC | $13.5M | 6.57% | 179,036 | Common | SOLE |
| 49177J102 | KVUE | KENVUE INC | $8.3M | 4.02% | 480,517 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $6.2M | 3.01% | 53,982 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $6.1M | 2.97% | 115,958 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $5.1M | 2.49% | 127,440 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $3.8M | 1.84% | 39,000 | PUT | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $3.8M | 1.82% | 38,593 | Common | SOLE |
| 68278B107 | K4F | ONESTREAM INC | $1.4M | 0.70% | 60,372 | Common | SOLE |
| 874054109 | TTWO | TAKE-TWO INTERACTIVE SOFTWAR | $1.3M | 0.62% | 6,500 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $678,061 | 0.33% | 31,626 | Common | SOLE |
| 04965N104 | RNA | ATRIUM THERAPEUTICS INC | $667,337 | 0.32% | 49,913 | Common | SOLE |
| 00510N102 | TIC | TIC SOLUTIONS INC | $508,891 | 0.25% | 77,339 | Common | SOLE |
| G5784H106 | MANU | MANCHESTER UTD PLC NEW | $250,954 | 0.12% | 14,920 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $119,498 | 0.06% | 10,025 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.